tm
Seeing Is Believing
tm
Seeing Is Believing
CADL is currently covered by 3 analysts with an average price target of $12.08. This is a potential upside of $4.24 (54.08%) from yesterday's end of day stock price of $7.84.
Candel Therapeutics's activity chart (see below) currently has 2 price targets and 7 ratings on display. The stock rating distribution of CADL is 100% BUY.
Highest price target for CADL is $2, Lowest price target is $1, average price target is $12.08.
Most recent stock forecast was given by EVAN SEIGERMAN from BMO on 15-May-2023. First documented stock forecast 23-Aug-2021.
Currently out of the existing stock ratings of CADL, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$1.3 (76.47%)
$18
1 years 7 months 30 days ago
(15-May-2023)
0/2 (0%)
$1.4 (87.50%)
Buy
1 years 9 months 14 days ago
(31-Mar-2023)
0/1 (0%)
$7.07 (89.16%)
What is CADL (Candel Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CADL (Candel Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CADL (Candel Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CADL (Candel Therapeutics)?
Which analyst is the currently most bullish on CADL (Candel Therapeutics)?
Which analyst is the currently most reserved on CADL (Candel Therapeutics)?
